MDCE Highlights StrainScan Pro for Multi-Billion-Dollar Cannabis Dispensary Sector with Enterprise iPad Air Solution (OTC Pink:MDCE)

Rhea-AI Summary

Medical Care Technologies (OTC Pink: MDCE) is promoting its already-launched StrainScan Pro, an AI-powered computer-vision platform aimed at licensed, multi-location cannabis dispensary operators. The software provides rapid visual strain identification and quality verification and is specifically optimized for deployment on Apple iPad Air devices, enabling on-device analysis without fixed industrial systems.

According to the company, StrainScan Pro targets the multi-billion-dollar U.S. cannabis retail sector by offering mobile, scalable tools to support consistent operations across locations. Medical Care Technologies emphasizes that it develops AI vision technology and does not cultivate, process, distribute, or sell cannabis, and notes it also generates revenue through subsidiaries Infinite Auctions and Real Game Used.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Proprietary AI Vision Platform Delivers Rapid Strain Identification and Quality Verification Tools for Licensed Multi-Location Dispensary Operators

MESA, AZ / ACCESS Newswire / August 13, 2026 / Medical Care Technologies Inc. (OTC PINK:MDCE) today highlighted the application of its already-launched StrainScan Pro platform for licensed cannabis dispensary operators, offering proprietary AI-powered visual identification and quality verification software designed for deployment on iPad Air devices.

StrainScan Pro is a proprietary computer-vision software platform. Medical Care Technologies develops and commercializes AI vision technology and does not cultivate, process, distribute, or sell cannabis. The platform is designed to assist licensed dispensary operators with rapid visual strain identification and quality verification at the retail level.

The U.S. cannabis retail sector represents a multi-billion-dollar market. As licensed operators manage multiple locations, the need for consistent, mobile, and scalable visual tools continues to grow. StrainScan Pro addresses this need with software optimized for simple installation on iPad Air hardware, enabling on-device analysis without fixed industrial systems.

"StrainScan Pro is live and available as a practical software tool for licensed dispensary operators," said Marshall Perkins, CEO of Medical Care Technologies. "By delivering it as proprietary AI vision software ready for iPad Air, we are giving multi-location retailers a flexible way to apply advanced visual identification technology on the floor in real time."

Investors and industry participants can explore the platform at: https://strainscanpro.com

Medical Care Technologies continues to apply its AI vision technology across high-value verticals while generating revenue through subsidiaries Infinite Auctions and Real Game Used.

About Medical Care Technologies Inc. Medical Care Technologies Inc. (OTC PINK:MDCE) is a diversified technology company focused on the development and commercialization of artificial intelligence-powered applications spanning health, wellness, nutrition, lifestyle, and enterprise imaging analysis solutions. The Company also owns subsidiaries Infinite Auctions and Real Game Used, which provide complementary revenue-generating operations. Visit: https://medicalcaretechnologies.com

Safe Harbor Statement This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on current expectations and assumptions, and actual results may differ materially due to various risks and uncertainties. The company undertakes no obligation to update these statements except as required by law. Investors are cautioned not to place undue reliance on forward-looking statements.

Contact Information: Medical Care Technologies Inc. 1910 S. Stapley Drive, Suite 221, Mesa, AZ 85204 Phone: +1 (480) 645-0750 Email: marshall@medicalcaretechnologies.com Websites: https://medicalcaretechnologies.com | https://strainscanpro.com

SOURCE: Medical Care Technologies Inc.

View the original press release on ACCESS Newswire

FAQ

What is StrainScan Pro from MDCE (OTC Pink: MDCE) and who is it for?

StrainScan Pro is an AI-powered computer-vision platform designed for licensed cannabis dispensary operators. According to Medical Care Technologies, it delivers rapid visual strain identification and quality verification tools focused on helping multi-location retailers standardize in-store assessment workflows at the retail level.

How does StrainScan Pro use iPad Air devices for cannabis dispensaries?

StrainScan Pro is optimized to run on Apple iPad Air devices, enabling on-device analysis. According to Medical Care Technologies, this avoids fixed industrial systems and supports mobile, scalable deployment across retail floors, helping licensed cannabis dispensary operators implement visual identification tools at multiple locations.

Does Medical Care Technologies (MDCE) handle or sell cannabis with StrainScan Pro?

Medical Care Technologies states it does not cultivate, process, distribute, or sell cannabis. According to the company, its role is limited to developing and commercializing AI vision technology, including StrainScan Pro, which is offered as software for licensed cannabis dispensary operators to use in their own businesses.

How can dispensary operators access MDCE’s StrainScan Pro platform?

Dispensary operators can explore StrainScan Pro by visiting the dedicated website at https://strainscanpro.com. According to Medical Care Technologies, the site provides information about the AI vision platform, its capabilities for strain identification, and its deployment model on Apple iPad Air devices.

What markets and applications does Medical Care Technologies (MDCE) target with its AI vision technology?

Medical Care Technologies focuses on AI-powered applications across health, wellness, nutrition, lifestyle, and enterprise imaging analysis. According to the company, it also applies its AI vision technology to high-value verticals like cannabis dispensary tools while operating revenue-generating subsidiaries Infinite Auctions and Real Game Used.

What other revenue-generating businesses does MDCE operate besides StrainScan Pro?

Beyond StrainScan Pro, Medical Care Technologies owns subsidiaries Infinite Auctions and Real Game Used. According to the company, these businesses provide complementary revenue-generating operations alongside its AI vision efforts, supporting a diversified technology model that spans several application areas and markets.